Athos Capital’s Globus Medical GMED Stock Holding History

Athos Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-59,200	Closed	-$3.52K	–	59
2023 Q2	$3.52K	Buy	+59,200	New	+$3.37M	2.75%	13

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Athos Capital's GMED Position: Q3 2023 in Review

Athos Capital sold out of Globus Medical (GMED) in Q3 2023, closing a stake of 59,200 shares — an estimated $3.52K sold.

Athos Capital first reported a position in GMED in Q2 2023 and held it in 1 quarter. The position peaked at $3.52K in Q2 2023. 431 funds tracked by Wall St. Rank hold GMED as of Q3 2023.

Athos Capital reported no remaining Globus Medical position as of Q3 2023 after selling out during the quarter.
Athos Capital sold 59,200 Globus Medical shares in Q3 2023, an estimated $3.52K.
Athos Capital first reported a position in Globus Medical in Q2 2023 and held it in 1 quarter.
Athos Capital's Globus Medical position peaked at $3.52K in Q2 2023.
431 funds tracked by Wall St. Rank held Globus Medical as of Q3 2023.

Based on Athos Capital's 13F filing for Q3 2023, filed 14 Nov 2023.